“India will be known as a vaccine superpower after Covid-19”
- -Dr Balram Bhargava, DG, ICMR
A hmasa berah chuan, vaccination drive kan kalpuina a frontline worker leh healthcare professional te thawhrah vang chauhin tun kan dinhmun hi kan thleng thei a ni. A pahnihna ah chuan khawvela immunization programme, nausen, naupang leh nau pawm nute tana kan kalpui thei hi ministry of health chak zia ti lang chiang tu a ni. A pathumna ah chuan vaccination drive hlawhtling taka kalpui a nih theihna tura sawrkar peng hrang hrangte tanrualna hi hmaih chi a ni lova. NITI Aayog, Indian Council of Medical Research leh NEGVAC te bakah committee hrang hrang leh ministry hrang hrang a bikin health ministry te tanrualna hi entawntlak tak a ni.
Sawrkar chuan lungrual takin public-private partnership a tul angin a kalpui thei a, hei hian hun harsa tak karah min hlawhtlin tir a ni. CoWIN siam chhuah lai a ni emaw group hrang hrang tana vaccination kalpui lai a ni emaw, hmun hrang hranga vaccination drive kalpui a nih avang khan 100 crore vaccine kan pe chhuak thei ta a ni. Heng zawng zawngte bakah hian kan ram chuan public health a ngaih pawimawh zia a tarlang.
Vaccine siam chhuah lai leh partnership kalpui laia pawimawh ber ka tih chu lungrual taka sawrkar leh private partner te an thawkdun thei kha a ni a. ICMR in Bharat Biotech a ring a, Bharat Biotech pawhin ICMR a ring a ni.
A tir atang khan kan hmalakna in scientific nghahchhan a nei tur a ni kan ti a, kan hmalakna te hi a vaiin scientific journal kan dah chhuak vek bawk. Kan hriat theuh angin international academia chuan Covaxin siam chhuah dan te an rawn ngai pawimawh a, paper 15 ah publish a ni tawh. Heng publication te hian global scientific literature ah hlut a hlawh hle a, vaccine siamchhuahna tura hma kalna hrang hrang- preclinal development, small animal studies, hamster studies, large animal studies leh clinical trails zawng zawng phase-III trial te thleng khan ngaih pawimawh a hlawh a, khawvela enchhina lian ber a ni. Heng zirchianna ah te hian virus variant hrang hrang Alhpa, Beta, Gamma, Delta vaccine in a hneh dan te tarlan vek a ni.
Covaxin siam chhuahna kalkawng ah khan ram chhunga science leh public health changtlun zia a tarlang.
A hmasa berah chuan, he kan kalkawng hian India inrintawkna a ti thar leh a, khawvela pharmacy-a a chungnung na ai mahin he inrintawkna hi thil tha a ni. He inrintawkna avang hian kan rama industry leh academia te vaccine thar siam chhuak turin phurna a pe a, tun hun hi vaccine thar emaw natna dang lo chhuak leh thei damna tur kan zawnchhuah nana pawimawh tak a ni. Heng te hi kan ram mipuite tan chauh ni lovin khawvel tana kan pek theih tura ruahman tur a ni a, he inpekna hi ‘Vasudhaiva Kutumbakam’ emaw ‘khawvel hi chhungkhat kan ni’ tihna a ni.
A pahnihna ah chuan, kum sawm chuang kan ram hi generic drug making ah kan lar tawh a. Hei vang hian Covid-19 dona kawnga te leh damdawi siamchhuahna ah te kawng thar min kai tur. Hei hi chhunzawm reng tlak niin industry leh academia te nasa zawkin an thahwduh a ngai ang. Engineering space lamah hemi kawng hi kan zawh mek a, IIT mithiam ten cosultation leh innovation lamah an pui nasa a ni. Medical science leh biomedical space ah he kawng hi zawh a ngai. Kan academia ten thil thar hmuchhuah te intellectual property leh innovation lamah te tan an la thei dawn a ni. He kawng hi kan zawhtur pawimawh tak a ni.
Tunah hian kan vaccination kalpui hi a chak hle niin ka hria a, kan target pawh kan tlin thuai dawn. Khawvel in tunah hian min thlir mek a, vaccination drive kan kalpui dan hi a zahawm bakah a mawi a ni.